The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

A well-marbled steak is highly prized for grilling, but those sort of fat deposits in human muscles can be deadly, a ...

Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...

The current approach, which initiates medications and escalates to mechanical circulatory support, has not resulted in a ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Overweight scores continue from 25-30. And over 30 is obese. Quetelet merely used this early calculation as a descriptor. He did not make any medical proclamations. The Quetelet Index became ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

Breakthrough therapy designation recognises the potential of brelovitug to transform the lives of people living with CHD. We ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...